Equity Overview
Price & Market Data
Price: $10.64
Daily Change: -$0.20 / 1.88%
Daily Range: $10.28 - $10.96
Market Cap: $364,472,224
Daily Volume: 96,058
Performance Metrics
1 Week: -6.17%
1 Month: -12.21%
3 Months: -21.36%
6 Months: -17.39%
1 Year: -8.04%
YTD: -21.01%
Company Details
Employees: 19
Sector: Health technology
Industry: Biotechnology
Country:
Details
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.